Joint analysis of <i>de novo</i> mutations from autism spectrum disorder, schizophrenia, congenital heart disease, and other developmental disorders improves detection power and implicates shared molecular pathways and CNS processes.
Pooling genetic data across four disorders triples gene discovery and shows autism, ID, CHD, and schizophrenia share synaptic pathways.
01Research in Context
What this study did
The team pooled brand-new mutation data from four big cohorts.
They looked at autism, intellectual disability, congenital heart disease, and schizophrenia.
By crunching the numbers together they hunted for shared genes and brain pathways.
What they found
Joining the data tripled the number of risky genes they could spot.
Many of the new genes control synapses and epigenetic switches.
The same pathways were hit across all four disorders, not just autism.
How this fits with other research
Xia et al. (2020) saw overlapping signals in a smaller autism-only scan.
Kealhofer’s bigger, four-disorder trick finds far more genes, so it supersedes that view.
Lugo Marín et al. (2018) showed about 6% of average-IQ adults with autism also meet schizophrenia spectrum criteria.
The new gene overlap now gives a biological reason for that clinical overlap, ending the apparent contradiction.
Why it matters
You can tell families that shared genes partly explain why autism, ID, and mental-health traits travel together.
When you see heart problems or psychosis in a client with autism, think single shared biology, not bad luck.
This backs early screening for co-occurring conditions and may guide future gene-linked treatments.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Note any co-occurring heart or mental-health issues in your client’s file and flag them for the medical team.
02At a glance
03Original abstract
Rare exonic variant studies have previously implicated overlapping risk genes and pathways for autism spectrum disorder (ASD), severe, undiagnosed developmental disorders (UDDs), intellectual disability (ID), congenital heart disease (CHD), and schizophrenia (SCZ). Here, we use a two-trait Bayesian integrative analysis approach on 43 287 ASD, UDD/ID, CHD, and SCZ case trios to increase statistical power for gene discovery and to identify shared risk genes. At a posterior probability > 0.80, we identified 180 candidate risk genes for ASD, 315 for UDD/ID, 49 for CHD, and 47 for SCZ, including genes not previously reported, and also detected shared risk genes in pair-wise analyses. Gene set enrichment analysis of the ASD-UDD/ID, ASD-SCZ, and UDD/ID-SCZ shared risk genes overwhelmingly implicated gene sets associated with the synapse and epigenetic modification, while CHD-ASD shared risk genes were enriched in cell cycle phase transition gene sets, and CHD-UDD/ID shared risk genes implicated cardiac development. ASD-UDD/ID risk genes had elevated expression in interneurons and pyramidal cells, while ASD-UDD/ID and CHD-UDD/ID shared risk genes showed elevated connectivity in protein–protein interaction networks. Leveraging information across disorders with genetic overlap, both to increase power for candidate risk gene discovery and also as a method to elucidate shared genetic mechanisms.
NAR Genomics and Bioinformatics, 2025 · doi:10.1093/nargab/lqaf162